Skip to main content
ENGN
NASDAQ Life Sciences

enGene Posts Q3 Loss, Sets BLA Filing for Detalimogene in Q4

Tom Rudovsky · Reported by BusinessWire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$1.81
Mkt Cap
$121.921M
52W Low
$1.4
52W High
$12.25
52W Position info
29% above low
Off High info
85% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

ENGN sits 29% above its 52-week low of $1.4.

Summary

enGene reported Q3 2026 results with a net loss of $32.5M ($0.47/share) and cash of $266.3M. The company reiterated plans for a pre-BLA meeting and BLA filing initiation in Q4 2026 for detalimogene in BCG-unresponsive NMIBC. The surfactant safety run-in has been cleared and a new cohort is enrolling. A KOL webinar is set for October 15, 2026. This follows the June 2026 workforce reduction and executive departures; the company is now focused on regulatory execution.

At the time of this announcement, ENGN was trading at $1.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $121.9M. The 52-week trading range was $1.40 to $12.25. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

ENGN - Latest Insights

ENGN
Nov 12, 2026, 11:33 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $2.21
Real-time Price: $1.70 info
Change: -$0.510 (-23%) info
Market Cap: $116.608M info
ENGN
Nov 12, 2026, 6:14 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.89
Real-time Price: $1.70 info
Change: -$0.190 (-10%) info
Market Cap: $116.608M info
ENGN
Nov 12, 2026, 1:39 AM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $1.82
Real-time Price: $1.70 info
Change: -$0.120 (-7%) info
Market Cap: $116.608M info
ENGN
Sep 08, 2026, 7:33 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.81
Real-time Price: $1.70 info
Change: -$0.110 (-6%) info
Market Cap: $116.608M info
ENGN
Jul 17, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.82
Real-time Price: $1.70 info
Change: -$0.120 (-7%) info
Market Cap: $116.608M info